Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy
about
Circulating biomarkers to monitor cancer progression and treatmentNew Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesThe impact of extracellular vesicle-encapsulated circulating microRNAs in lung cancer researchMTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b.Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseasesThe association between abnormal microRNA-10b expression and cancer risk: a meta-analysis.A miRNA signature of chemoresistant mesenchymal phenotype identifies novel molecular targets associated with advanced pancreatic cancer.MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal AdenocarcinomaMicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer.Plasma miR-19b and miR-183 as Potential Biomarkers of Lung Cancer.MicroRNA-9 is a ponderable index for the prognosis of human hepatocellular carcinomaIntegrative transcriptome analysis identifies deregulated microRNA-transcription factor networks in lung adenocarcinoma.A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.The role of microRNAs in lung cancer progression.The validity of circulating microRNAs in oncology: five years of challenges and contradictions.Good guy or bad guy: the opposing roles of microRNA 125b in cancerTargeting the microRNA-regulating DNA damage/repair pathways in cancer.MicroRNAs in lung cancer.A meta-analysis: microRNAs' prognostic function in patients with nonsmall cell lung cancer.Regulation of expression of microRNAs by DNA methylation in lung cancer.The role of exosomes and miRNAs in drug-resistance of cancer cells.MicroRNA-125b in peripheral blood: a potential biomarker for severity and prognosis of children with viral encephalitis.Letter: Micro-RNA-125b and its use as a biomarker of systemic malignancies besides urothelial cancersMicroRNA-125b-5p inhibits proliferation and promotes adipogenic differentiation in 3T3-L1 preadipocytes.Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer.MicroRNA-9 enhances sensitivity to cetuximab in epithelial phenotype hepatocellular carcinoma cells through regulation of the eukaryotic translation initiation factor 5A-2.MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas.The functional mechanism of miR-125b in gastric cancer and its effect on the chemosensitivity of cisplatin.Prognostic value of microRNA-10b overexpression in peripheral blood mononuclear cells of nonsmall-cell lung cancer patients.miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives.
P2860
Q26745985-18545A9D-879B-4A86-8457-1ED6EAD3F17DQ26748881-32A911F6-D745-4CFD-A97A-C1AC49AEFB51Q34252557-6BF32C85-87D3-4D65-AE16-7933B2360F8DQ34347485-E58DFF3F-6A99-43C1-9F94-878992928F8AQ34391443-77BD4029-1B39-48A5-9F48-483CA2C594B0Q34708173-1EFACFEB-7AAC-4249-BB90-7293EC44F8F7Q35237480-E55D9225-D0D4-40E6-B68A-4078B89D9C32Q35852437-5575E2AF-9C74-456F-877B-63F4074FD1D8Q36069369-B43FBDD8-9541-4DBD-AB86-3EF04611604CQ36170868-A2D2A382-3599-464E-B0B3-BA1CCFCFBC88Q36411622-02739F12-4EDB-4128-8BF9-CCA6BC29A6E4Q37301705-4FFE44EF-4EDE-40B3-9821-2544E2C8D820Q37529831-0FEAC671-7D10-48DE-A47A-77B10C93B127Q38127375-145876B1-67F0-4FF1-8F8E-D4EBFC688C64Q38198366-01FD5D41-16B1-4933-AC83-AC314AC6B9AFQ38207752-69525E07-397C-4D86-8310-E0B4E389B70EQ38246220-37FA50B8-9BB6-4381-AEA1-1CBA24A0E2FCQ38261676-5BEEAB62-0587-43DB-85A6-4F755C548C83Q38624030-D2A752C0-5596-434F-B14F-C928F03BE93AQ38819457-2228BA0E-A4FA-46C8-A463-211AF87C01B7Q39152624-DB50450A-AC72-4D67-A059-4DE7766E9D97Q40202310-0992181C-1DD2-4717-BA96-7197F4F9B38FQ40611991-388AB10D-3645-42CA-BB7F-F450CF2E05B2Q41006922-1CDF8EC6-EF3D-4480-ABCC-A0E0AB178888Q47428325-2AF8FFC4-BF46-4E73-8AC5-F2E6EADA02A7Q49335206-BB80F02B-E8D3-4532-AEF8-FF94B2F0BA2EQ49409530-F6E3306D-D5CB-4FFF-873A-6D76FAA0FBF7Q50054688-461837ED-3097-431C-B1F1-6CA633E9A008Q52951826-FC12DB89-60EB-4E8F-816C-BB609C383927Q53189857-3650F007-26E1-4688-A1E8-4FB0E304D53D
P2860
Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Serum microRNA 125b as a diagn ...... g cisplatin-based chemotherapy
@ast
Serum microRNA 125b as a diagn ...... g cisplatin-based chemotherapy
@en
Serum microRNA 125b as a diagn ...... cisplatin-based chemotherapy.
@nl
type
label
Serum microRNA 125b as a diagn ...... g cisplatin-based chemotherapy
@ast
Serum microRNA 125b as a diagn ...... g cisplatin-based chemotherapy
@en
Serum microRNA 125b as a diagn ...... cisplatin-based chemotherapy.
@nl
prefLabel
Serum microRNA 125b as a diagn ...... g cisplatin-based chemotherapy
@ast
Serum microRNA 125b as a diagn ...... g cisplatin-based chemotherapy
@en
Serum microRNA 125b as a diagn ...... cisplatin-based chemotherapy.
@nl
P2093
P2860
P921
P356
P1476
Serum microRNA 125b as a diagn ...... g cisplatin-based chemotherapy
@en
P2093
En-hai Cui
Hong-jiao Li
Jian-you Li
Xiang Wang
Xue-ren Feng
P2860
P2888
P304
P356
10.1038/APS.2012.125
P577
2012-09-17T00:00:00Z
P5875
P6179
1030167441